학술논문
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022
Document Type
Article
Author
Fowlkes, A.L.; Grant, L.; Yoo, Y.M.; Mak, J.; Lamberte, J.M.; Jones, J.T.; Thompson, M.G.; Yoon, S.K.; Phillips, A.L.; Thiese, M.S.; Hegmann, K.T.; Lutrick, K.; Rivers, P.; Gwynn, L.; Ferraris, M.V.; Solle, N.S.; Ochoa, J.S.; Pubillones, F.A.; Caban-Martinez, A.J.; Burns, J.; LeClair, L.B.; Jeddy, Z.; Berry, M.; Rai, R.P.; Edwards, L.J.; Sokol, B.E.; McLeland-Wieser, H.; Fleary, D.E.; Poe, B.; Lopez, J.; Olsho, L.E.W.; Ellingson, K.; Gerald, L.B.; Gerald, J.K.; Madhivanan, P.; Krupp, K.; Bedrick, E.J.; Lowe, A.; Jovel, K.S.; Khan, S.M.; Hollister, J.; Beitel, S.; Burgess, J.L.; Mathenge, C.; Odame-Bamfo, L.; Rose, S.; Dunnigan, K.; Tyner, H.L.; Naleway, A.L.; Gaglani, M.
Source
In: MMWR Recommendations and Reports . (MMWR Recommendations and Reports, 2022, 71(11):422-428)
Subject
Language
English
ISSN
15458601
10575987
10575987